The aim of our work was to investigate a possible role of protein kinase C (PKC) in insulin-stimulated glucose uptake in mouse skeletal muscle, and to search for a defect in PKC activation in insulin resistance found in obesity. In isolated soleus muscle of lean mice, insulin (100 nM) and 12-0-tetradecanoylphorbol 13-acetate (TPA) (1 #M) acutely stimulated glucose uptake 3-and 2-fold respectively. The effects of insulin and TPA were not additive. When PKC activity was down-regulated by long-term (24 h) TPA pretreatment, before measurement of glucose transport, the TPA effect was abolished, but in addition insulin-stimulated glucose transport returned to basal values. Furthermore, polymyxin B, which inhibits PKC in muscle extracts, prevented insulin-stimulated glucose uptake in muscle. In muscle of obese insulin-resistant mice, glucose uptake evoked by insulin was decreased, whereas the TPA effect, expressed as a fold increase, was unaltered. Thus both agents stimulated glucose transport to the same extent. Furthermore, no difference was observed when PKC activation by TPA was measured in muscle from lean and obese mice. These results suggest that: (1) PKC is involved in the insulin effect on glucose transport in muscle; (2) PKC activation explains only part of the insulin stimulation of glucose transport; (3) the defect in insulin response in obese mice does not appear to be due to an alteration in the PKC-dependent component of glucose transport. We propose that insulin stimulation of glucose uptake occurs by a sequential two-step mechanism, with first translocation of transporters to the plasma membrane, which is PKC dependent, and second, activation of the glucose transporters. In obesity only the activation step was decreased, whereas the translocation step was unaltered.
INTRODUCTION
Insulin binding to its receptor initiates a large array of cellular events, among them stimulation of glucose uptake in adipocytes and muscle. Currently, the molecular steps between the hormone binding and the increase in glucose uptake are not totally elucidated (Rosen, 1987; Gammeltoft & Van Obberghen, 1986) . Activation of the receptor tyrosine kinase activity plays a key role in this process, since cells transfected with insulin receptors, lacking kinase activity owing to mutagenesis of the ATP-binding site, are unable to respond to insulin (Chou et al., 1987; Ebina et al., 1987) . Likewise, modifications of insulin-stimulated glucose transport are associated with parallel alterations in insulin-receptor tyrosine kinase activity (Debant et al.,. 1987; Freidenberg et al., 1987; Le Marchand-Brustel et al., 1985) . However, the intermediary steps between activation of insulin-receptor tyrosine kinase activity and stimulation of glucose transport are entirely unknown.
Phorbol esters, which bind to and activate a Ca2+-and phospholipid-dependent kinase (protein kinase C, PKC), exert insulin-like effects on glucose and amino acid transport, lipogenesis from glucose, and activation of pyruvate dehydrogenase (Cherqui et al., 1986; Farese et al., 1985; Kirsch et al., 1985 ; Van de Werve et al., 1985) . PKC activation could thus be an important step in transducing part of the insulin signal. Several lines of evidence have suggested that the phosphatidylinositol cycle could be the link between insulin-receptor kinase and activation of glucose uptake (Kirsch et al., 1985; Van de Werve et al., 1985) . For instance, insulin is able to activate phospholipase C in isolated rat adipocytes (K6pfer-Hobelsberger & Wieland, 1984) . In BC3H-1 myocytes, insulin increases both diacylglycerol content, via synthesis de novo of phosphatidic acid and phosphoinositides, and PKC activity (Farese et al., 1985; Cooper et al., 1987) . Hearts of obese fa/fa rats are both insulin-and TPA-resistant for glucose uptake, and exhibit a total unresponsiveness to TPA-induced protein kinase C translocation (Van de Werve et al., 1987) . By contrast, some reports have shown that PKC depletion induced by long-term exposure to TPA had no effect on insulin-stimulated glucose uptake (Klip & Ramlal, 1987) .
In the present work we have looked for the involvement of PKC in the effect of insulin on glucose transport in skeletal muscle, a major site of glucose utilization. We then investigated whether an alteration in this pathway could explain, in part, the insulin-resistance of glucose uptake in skeletal muscle of obese mice. To answer these questions, we studied TPA-stimulated glucose uptake and PKC activation in soleus muscle of mice rendered obese and insulin-resistant by gold-thioglucose injection and which display decreased insulin-receptor kinase activity and glucose transport Le Marchand-Brustel et al., 1978 .
Abbreviations used: PKC, protein kinase C; TPA, 12-0-tetradecanoylphorbol 13-acetate.
MATERIALS AND METHODS

Materials.
Radioactive substances were from Amersham International, Amersham, Bucks., U.K. DEAE-cellulose DE52 was from Whatman. Phospholipids, histones, TPA, polymyxins, phorbol esters and other chemicals were from Serva or Sigma (St. Louis, MO, U.S.A.). TPA was dissolved in ethanol, and equal volumes of solvent were added to control and insulin-treated muscles.
Animals
Male Swiss albino mice (7-8 weeks old) were given laboratory chow ad libitum (Usine d'Alimentation Rationelle, Villemoisson, Epinay/Orge, France) and maintained at 23°C on a 12 h-light cycle until the time of experiment. Mice were rendered obese by gold-thioglucose injection at 3 weeks of age and were used at 25-30 weeks, when obesity had reached a plateau . In experiments with obese mice, age-matched lean control animals were used. Soleus-muscle incubation and measurement of 2-deoxyglucose uptake Soleus muscles from lean and obese mice were isolated as previously described (Le Marchand-Brustel et al., 1978) , and preincubated for 15 min at 37°C in Krebs-Ringer bicarbonate buffer, pH 7.4, containing defatted bovine serum albumin (10 mg/ml) and 2 mmsodium pyruvate. Muscles were then incubated for 30 min in the absence or the presence of insulin (0.5-100 nM), TPA (1 /tM) or polymyxins. 2-Deoxy-D-[l-'4C1-glucose (0.5 mm, 0.1 ,uCi) was added for 15 min in the same medium. Uptake was terminated by washing the muscles for 30 min in ice-cold iso-osmotic NaCl solution, and the muscles were dissolved in 1 M-NaOH. Radioactivity of samples was counted and protein concentration was determined (Lowry et al., 1951) . Results are expressed as means + S.E.M. for the numbers of muscles indicated in legends to Figures or Tables. Down-regulation of PKC Isolated soleus muscles of lean mice were incubated for 24 h at 37°C in Krebs-Ringer bicarbonate buffer containing defatted serum albumin (10 mg/ml), 15 mmglucose, bacitracin (1 mg/ml) and gentarnycin (50 jug/ml) with or without 1 1sM-TPA. After this incubation, to remove phorbol ester, muscles were washed for 3 x 20 min with Krebs-Ringer bicarbonate buffer containing 1 % defatted bovine serum albumin and 2 mM-pyruvate before measurement of 2-deoxyglucose transport as described above.
Determination of PKC activity
To measure PKC activation by TPA in obese or lean mice, soleus muscles were incubated in Krebs-Ringer bicarbonate buffer without or with TPA (1 /LM) as described above. Thereafter, each muscle was homogenized by brief sonication in 500 ,u of ice-cold 20 mMTris/HCl buffer (pH 7.4) containing 0.33 M-sucrose, 0.5 mM-EGTA, 2 mM-EDTA and leupeptin (25 ,ug/ml).
The homogenate was centrifuged for 20 min at 15 000 g. The supernatant will be termed 'cytosolic fraction'. In this fraction, protein kinase activity was measured as described by Klip & Ramlal (1987) with minor modifications. Briefly, subcellular fractions were passed through a 0.5 ml DE52 (DEAE-cellulose) column to remove. endogenous lipids, diacylglycerol and kinase inhibitors. Columns were washed with 5 vol. of 20 mm Tris/HCl buffer (pH 7.4) / 2 mM-EDTA / 0.5 mM-EGTA / 2 mMphenylmethanesulphonyl fluoride and eluted with 1.5 ml of the same buffer supplemented with 100 mM-NaCl.
PKC activity was measured with histone type IIIS (Sigma) as substrate. Assays were performed for 30 min at 20°C with 100 ,u of each fraction in a final volume of 250 u1l of 20 mM-Tris/HCl buffer (pH 7.5) containing [y-32P]ATP (5 ,Ci; 50 4aM), 10 mM-magnesium acetate, 0.75 mM-CaCl2 and 25 ,cg ofhistone IIIS. At the end ofthe incubation, samples were adsorbed on phosphocellulose P81 paper, and extensively washed in 1 % H3P04 solution. PKC activity was measured in the absence (basal kinase activity) or the presence of 24 ,ug of phosphatidylserine and 1.6 ,tg of 1,2-diolein. PKC activity was calculated by subtracting basal activity from phosphatidylserine/diolein-stimulated activity (basal activity was 10-20 % of stimulated activity and was not changed when muscles were incubated without or with TPA).
RESULTS
Effect of insulin and TPA on 2-deoxyglucose transport in soleus muscle of lean mice To search for a role of PKC in stimulation of glucose transport, soleus muscles were incubated with insulin and TPA for 30 min before measurement ofdeoxyglucose uptake. As shown in Fig. 1 , insulin (100 nM) stimulated deoxyglucose uptake by 3-fold, half-maximal effect being obtained at 0.5 nm. The phorbol ester TPA (1 /ZM) increased this uptake by 1.7-fold, and was thus as efficient as a half-maximal insulin concentration. For the concentrations of insulin used (0.5 or 100 nM), the effects of insulin and TPA were not additive. Effect of PKC depletion on glucose uptake To look more directly for a role of PKC in glucose transport, muscles were preincubated for 24 h with TPA (1 /M). As described in different cell types, this treatment induced down-regulation of PKC in muscles also. Indeed, PKC activity was 23.1 + 2.8 and 2.8 + 1.0 pmol/assay (means + S.E.M. for five muscles preincubated without or with TPA respectively). We then measured 2-deoxyglucose uptake in the presence of insulin and TPA, after extensive washes to remove the phorbol ester. As shown in Table 1 , basal deoxyglucose uptake was similar whether the 24 h preincubation was performed in the absence or the presence of TPA. Consistent with a downregulation of PKC, preincubation with the TPA rendered the muscle unresponsive to this agent. Moreover, stimulation of glucose uptake by insulin was also abolished after this PKC down-regulation. Effect of polymyxin B on deoxyglucose uptake in soleus muscles
To substantiate further a role for PKC in insulinstimulated glucose uptake, we studied the effect of polymyxin B, an inhibitor of PKC (Mazzei et al., 1982; Wise et al., 1982) . As shown in Table 2 , polymyxin B abolished PKC activity when added to DEAE-cellulose eluates obtained from soleus-muscle homogenates, whereas polymyxin E, which differs from polymyxin B by only one amino acid residue, was completely ineffective. Furthermore, when polymyxin B was added to isolated soleus muscles, it caused a concentrationdependent inhibition of insulin-stimulated glucose uptake, whereas basal uptake was unchanged (Fig. 2) . By contrast, polymyxin E did not affect this insulin effect (Gremeaux et al., 1987 analysed the effects of TPA in muscle of mice rendered obese by gold-thioglucose injection. These mice are markedly obese and insulin-resistant . As shown in Fig. 3 and as previously documented (Le Marchand-Brustel et al., 1978; Cuendet et al., 1976) , in muscle of obese mice basal deoxyglucose uptake was slightly, but significantly, decreased compared with control mice (P < 0.025). This alteration of glucose uptake in basal conditions makes the interpretation of stimulatory effects of insulin or TPA more complex. Thus muscles from obese mice were markedly resistant to insulin whether results of insulin stimulation were expressed as a fold increase (1.8-fold, compared with 2.7-fold in lean mice) or in absolute values (Fig. 3) . This is different from what was observed with TPA: in absolute terms, TPA-stimulated uptake was lower in obese than in lean mice, but, when expressed as a fold stimulation, TPA stimulation was as efficient in obese-as in lean-mouse muscles (1.7-fold compared with 1.9-fold). Furthermore, in obese-mouse muscles the TPA (Nishizuka, 1986) . As shown in Table 3 , in basal conditions, in the absence of TPA, PKC activity was identical in the cytosolic fraction of lean-and obese-mouse muscles (no differences were observed in the Ca2+/phospholipidindependent kinase activities; results not shown). After TPA treatment, PKC activity decreased by 40 % in the cytosolic fraction, in both lean and obese mice. Those results show that in skeletal muscles of obese mice TPAinduced PKC translocation was unaltered.
DISCUSSION
Previous studies have suggested that the phosphatidylinositide cycle might participate in insulin action through activation of PKC. This conclusion was supported by the observation that phorbol esters, which activate PKC, exert insulin-like effects in adipocytes, myocytes and heart muscle (Farese et al., 1985; Kirsch et al., 1985; Van de Werve et al., 1985) . In the present work, we have studied TPA effects on glucose transport in isolated soleus muscle. Indeed, skeletal muscle is the major site of glucose utilization in vivo, and an important target tissue for insulin action. The phorbol ester TPA was able to increase glucose transport by 1.5-fold in soleus muscle, an effect that was 500 of the maximal insulin effect. This result differs from those reported by Sowell et al. (1988) , who did not observe an effect of phorbol esters in rat skeletal muscle, the reason for this discrepancy being at present unclear. Our data suggest that activation of PKC could be a regulator of glucose uptake in skeletal muscle. To search for a role of this enzyme in insulin stimulation of glucose uptake in muscle, the hormone effect has been studied under two conditions: (1) after down-regulation of PKC by long-term preincubation with TPA; (2) in the presence of polymyxin B, which inhibits PKC activity (Mazzei et al., 1982; Wise et al., 1982;  Table 2 ). In both cases, insulin-stimulated deoxyglucose uptake was markedly decreased, but basal uptake was unaffected. Although polymyxin B or TPA might have multiple actions, these results point to a role of PKC in the effect of insulin on glucose transport in muscle.
In muscle, as in most previously studied systems (Kirsch et al., 1985; Van de Werve et al., 1985; Miihlbacher et al., 1988) , TPA, which maximally activates PKC, is only able to elicit part of the full insulin response. This suggests that the stimulatory action of insulin on glucose uptake involved not only a PKCdependent mechanism, but also an additional component which cannot be mimicked by PKC activators. Stimulation of glucose transport by both insulin and TPA is thought to be due to a recruitment of glucose carriers from an intracellular pool to the plasma membrane (Miihlbacher et al., 1988; Kitagawa et al., 1985; Wardzala & Jeanrenaud, 1981; Cushman & Wardzala, 1980) . However, although these compounds produce the same increase in plasma-membrane carrier sites, the magnitude of the insulin effect on glucosetransport activity surpasses the effect of TPA. Furthermore, the effect of insulin on the translocation of glucose transporters cannot account quantitatively for the complete insulin-induced glucose transport. To explain the discrepancy between the magnitude of the insulin effect on the increase in glucose transporters in the plasma membrane and on glucose uptake, it has been proposed that in adipocytes or in heart muscle insulin activates glucose carriers after their translocation (Baly & Horuk, 1987; Greco-Perotto et al., 1987; Miihlbacher et al., 1988; Zaninetti et al., 1988 (Blackshear et al., 1987) . Likewise, polymyxin B blocks the insulin action solely on membrane transport without affecting hormonal activation of glycogen synthase or insulin's antilipolytic effects (Gremeaux et al., 1987; Amir et al., 1987) .
We then looked for the PKC functioning in muscles of obese insulin-resistant mice. As previously reported, basal glucose uptake was slightly but significantly decreased in muscle from obese mice compared with lean animals, a decrease which can be accounted for by a lower number of glucose transporters, as described in heart muscle of obese Zucker rats or in adipocytes of obese patients (Garvey et al., 1988 Taken together, our results suggest that the defect in insulin-stimulated glucose transport in obese mice is not due to an alteration in the PKC-dependent component. We propose that in muscles from obese mice the glucosetransporter translocation induced by insulin or TPA is normal, but that the subsequent activation step is defective. Thus the regulation of these two processes appears to be different. The decrease in insulin-stimulated glucose transport would result first, from a decreased number of glucose transporters, and second, from a defect in their activation once translocated to the plasma membrane. It is tempting to speculate that the activation of glucose transporters by insulin is a consequence of the insulin-receptor kinase action, a process which is also altered in obese insulin-resistant states (Freidenberg et al., 1987 ; Le Marchand-Brustel et al., 1985) . Although it Vol. 258 is clear that this receptor enzymic function is crucial for insulin-stimulated glucose transport (Chou et al., 1987; Ebina et al., 1987) , the cascade of events leading to the increase in glucose transport is still a matter of speculation. So far, it has not been possible to correlate a change in the phosphorylation state of the glucose transporter and a modification of its activity (Gibbs et al., 1986; Kohanski et al., 1986 
